ArticleClinical pharmacology and therapeutics2026
Machine Learning Model Predicts Clinical Adverse Events of Small Molecule Kinase Inhibitors in Cancer Patients Using On-/Off-Target Engagement and Tissue Selectivity.
Natalie M Jusko et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.